🇺🇸 FDA
Patent

US 6028198

Pharmaceutical composition for prevention and treatment of motion sickness syndrome

expired A61KA61K31/435A61K31/439

Quick answer

US patent 6028198 (Pharmaceutical composition for prevention and treatment of motion sickness syndrome) held by INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY SCIENCE P.L.A. CHINA expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY SCIENCE P.L.A. CHINA
Grant date
Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/435, A61K31/439